BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37343707)

  • 1. Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617.
    Lee SH; Geng H; Arnold J; Caruana R; Fan Y; Rosen MA; Apte AP; Deasy JO; Bradley JD; Xiao Y
    Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1270-1286. PubMed ID: 37343707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617.
    Thor M; Deasy JO; Hu C; Gore E; Bar-Ad V; Robinson C; Wheatley M; Oh JH; Bogart J; Garces YI; Kavadi VS; Narayan S; Iyengar P; Witt JS; Welsh JW; Koprowski CD; Larner JM; Xiao Y; Bradley J
    Clin Cancer Res; 2020 Sep; 26(17):4643-4650. PubMed ID: 32398326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer.
    Vivekanandan S; Landau DB; Counsell N; Warren DR; Khwanda A; Rosen SD; Parsons E; Ngai Y; Farrelly L; Hughes L; Hawkins MA; Fenwick JD
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):51-60. PubMed ID: 28816160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretable machine learning for predicting pathologic complete response in patients treated with chemoradiation therapy for rectal adenocarcinoma.
    Wang D; Lee SH; Geng H; Zhong H; Plastaras J; Wojcieszynski A; Caruana R; Xiao Y
    Front Artif Intell; 2022; 5():1059033. PubMed ID: 36568580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Methodology to Investigate the Effect of Radiation Dose to Heart Substructures on Overall Survival.
    McWilliam A; Khalifa J; Vasquez Osorio E; Banfill K; Abravan A; Faivre-Finn C; van Herk M
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1073-1081. PubMed ID: 32585334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Anterior Descending Coronary Artery Radiation Dose Association With All-Cause Mortality in NRG Oncology Trial RTOG 0617.
    McKenzie E; Zhang S; Zakariaee R; Guthier CV; Hakimian B; Mirhadi A; Kamrava M; Padda SK; Lewis JH; Nikolova A; Mak RH; Atkins KM
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1138-1143. PubMed ID: 36436615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Dose in Locally Advanced Lung Cancer: Results From a Statewide Consortium.
    Dess RT; Sun Y; Muenz DG; Paximadis PA; Dominello MM; Grills IS; Kestin LL; Movsas B; Masi KJ; Matuszak MM; Radawski JD; Moran JM; Pierce LJ; Hayman JA; Schipper MJ; Jolly S;
    Pract Radiat Oncol; 2020; 10(1):e27-e36. PubMed ID: 31382026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.
    Pham J; Neilsen BK; Liu H; Cao M; Yang Y; Sheng K; Ma TM; Kishan AU; Ruan D
    Med Phys; 2024 Jan; 51(1):612-621. PubMed ID: 38055353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explainable Artificial Intelligence to Identify Dosimetric Predictors of Toxicity in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0617.
    Ladbury C; Li R; Danesharasteh A; Ertem Z; Tam A; Liu J; Hao C; Li R; McGee H; Sampath S; Williams T; Glaser S; Khasawneh M; Liao Z; Lee P; Ryckman J; Shaikh P; Amini A
    Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1287-1296. PubMed ID: 37406826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
    Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
    J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer.
    Speirs CK; DeWees TA; Rehman S; Molotievschi A; Velez MA; Mullen D; Fergus S; Trovo M; Bradley JD; Robinson CG
    J Thorac Oncol; 2017 Feb; 12(2):293-301. PubMed ID: 27743888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
    Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
    J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617.
    Eaton BR; Pugh SL; Bradley JD; Masters G; Kavadi VS; Narayan S; Nedzi L; Robinson C; Wynn RB; Koprowski C; Johnson DW; Meng J; Curran WJ
    J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27206636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explainable deep learning-based survival prediction for non-small cell lung cancer patients undergoing radical radiotherapy.
    Astley JR; Reilly JM; Robinson S; Wild JM; Hatton MQ; Tahir BA
    Radiother Oncol; 2024 Apr; 193():110084. PubMed ID: 38244779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between cardiac irradiation and survival in patients with non-small cell lung cancer: Validation and new discoveries in an independent dataset.
    Vivekanandan S; Fenwick JD; Counsell N; Panakis N; Stuart R; Higgins GS; Hawkins MA
    Radiother Oncol; 2021 Dec; 165():119-125. PubMed ID: 34718053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation.
    Yegya-Raman N; Ho Lee S; Friedes C; Wang X; Iocolano M; Kegelman TP; Duan L; Li B; Berlin E; Kim KN; Doucette A; Denduluri S; Levin WP; Cengel KA; Cohen RB; Langer CJ; Kevin Teo BK; Zou W; O'Quinn RP; Deasy JO; Bradley JD; Sun L; Ky B; Xiao Y; Feigenberg SJ
    Radiother Oncol; 2024 Jan; 190():110005. PubMed ID: 37972736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Radiation Doses to the Heart on Survival for Stereotactic Ablative Radiotherapy for Early-stage Non-Small-cell Lung Cancer: An Artificial Neural Network Approach.
    Chan ST; Ruan D; Shaverdian N; Raghavan G; Cao M; Lee P
    Clin Lung Cancer; 2020 Mar; 21(2):136-144.e1. PubMed ID: 31932217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer.
    Borkenhagen JF; Bergom C; Rapp CT; Klawikowski SJ; Rein LE; Gore EM
    Clin Lung Cancer; 2019 Nov; 20(6):435-441. PubMed ID: 31303452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.